[Herpes therapy and prophylaxis. II. Results of a survey of practicing ophthalmologists (author's transl)].
Between December 1975 and April 1976, 2,300 ophthalmologists in the Federal Republic of Germany and West-Berlin were asked about their experiences with different forms of therapy and prophylaxis for herpetic eye diseases. 15 questions were answered by 965 ophthalmologists (42%). The answers not only reflect their preferences and experiences, but could also initiate a new evaluation of many diagnostic, therapeutic and prophylactic methods.
D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007635:Keratitis, Dendritic / Q000188:drug therapy* / Q000517:prevention & control; D007773:Lactates / Q000627:therapeutic use; D008628:Mercury / Q000627:therapeutic use; D012835:Silver Nitrate / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use; D015032:Zinc / Q000627:therapeutic use
D007773:Lactates; D012835:Silver Nitrate; D014740:Vidarabine; D008628:Mercury; D015032:Zinc; D007065:Idoxuridine
Herpestherapie und-prophylaxe. II. Das Ergebnis einer Umfrage bei niedergelassenen Augenärzten.